Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 1;11(3):43.
doi: 10.1038/s41408-021-00439-x.

Treatment outcome of clonal cytopenias of undetermined significance: a single-institution retrospective study

Zhuoer Xie  1 , Ahmad Nanaa  1 , Antoine N Saliba  1 , Rong He  2 , David Viswanatha  3 , Phuong Nguyen  2 , Dragan Jevremovic  3 , Patricia Greipp  2 , Mohamad E Salama  2 , Naseema Gangat  1 , Hassan B Alkhateeb  1 , Ayalew Tefferi  1 , Mark Litzow  1 , Mrinal Patnaik  1 , Mithun Shah  1 , Aref Al-Kali  4
Affiliations

Treatment outcome of clonal cytopenias of undetermined significance: a single-institution retrospective study

Zhuoer Xie et al. Blood Cancer J. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. Disease response rate (RR).
Number and percentage of responders based on the treatment types. HMA hypomethylating agents, T testosterone, CsA cyclosporin, IVIG intravenous immunoglobulin, RTX rituximab.
See this image and copyright information in PMC

References

    1. Bejar R. CHIP, ICUS, CCUS and other four-letter words. Leukemia. 2017;31:1869–1871. doi: 10.1038/leu.2017.181. - DOI - PubMed
    1. Steensma DP, et al. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood. 2015;126:9–16. doi: 10.1182/blood-2015-03-631747. - DOI - PMC - PubMed
    1. Malcovati L, et al. Clinical significance of somatic mutation in unexplained blood cytopenia. Blood. 2017;129:3371–3378. doi: 10.1182/blood-2017-01-763425. - DOI - PMC - PubMed
    1. Cargo CA, et al. Targeted sequencing identifies patients with preclinical MDS at high risk of disease progression. Blood. 2015;126:2362–2365. doi: 10.1182/blood-2015-08-663237. - DOI - PubMed
    1. Steensma DP. Clinical implications of clonal hematopoiesis. Mayo Clin. Proc. 2018;93:1122–1130. doi: 10.1016/j.mayocp.2018.04.002. - DOI - PubMed

LinkOut - more resources